433 related articles for article (PubMed ID: 7579412)
21. Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development.
Yamane T; Kunisada T; Yamazaki H; Nakano T; Orkin SH; Hayashi SI
Exp Hematol; 2000 Jul; 28(7):833-40. PubMed ID: 10907645
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
Elefanty AG; Robb L; Birner R; Begley CG
Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
[TBL] [Abstract][Full Text] [Related]
23. Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins.
Mead PE; Deconinck AE; Huber TL; Orkin SH; Zon LI
Development; 2001 Jun; 128(12):2301-8. PubMed ID: 11493549
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines.
Nagai T; Harigae H; Ishihara H; Motohashi H; Minegishi N; Tsuchiya S; Hayashi N; Gu L; Andres B; Engel JD
Blood; 1994 Aug; 84(4):1074-84. PubMed ID: 7519472
[TBL] [Abstract][Full Text] [Related]
25. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
Murrell AM; Green AR
Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
Goldfarb AN; Lewandowska K
Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
[TBL] [Abstract][Full Text] [Related]
27. Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells.
Bockamp EO; McLaughlin F; Göttgens B; Murrell AM; Elefanty AG; Green AR
J Biol Chem; 1997 Mar; 272(13):8781-90. PubMed ID: 9079714
[TBL] [Abstract][Full Text] [Related]
28. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain.
Green AR; Lints T; Visvader J; Harvey R; Begley CG
Oncogene; 1992 Apr; 7(4):653-60. PubMed ID: 1565464
[TBL] [Abstract][Full Text] [Related]
29. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
[TBL] [Abstract][Full Text] [Related]
30. Megakaryocytic differentiation of a leukemic cell line, MC3, by phorbol ester: induction of glycoprotein IIb/IIIa and effects on expression of IL-6, IL-6 receptor, mpl and GATA genes.
Okabe M; Kunieda Y; Shoji M; Nakane S; Kurosawa M; Tanaka J; Hansen SR; Asaka M
Leuk Res; 1995 Dec; 19(12):933-43. PubMed ID: 8632663
[TBL] [Abstract][Full Text] [Related]
31. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
32. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.
Tanigawa T; Nicola N; McArthur GA; Strasser A; Begley CG
Blood; 1995 Jan; 85(2):379-90. PubMed ID: 7811994
[TBL] [Abstract][Full Text] [Related]
34. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
35. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
37. Absence of SCL mutations in myeloid malignancies.
Delabesse E; Li J; Schnittger S; Hiddemann W; Green AR
Br J Haematol; 2003 Feb; 120(3):482-3. PubMed ID: 12580964
[TBL] [Abstract][Full Text] [Related]
38. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.
Ohyashiki K; Ohyashiki JH; Fujieda H; Shimamoto T; Kawakubo K; Nakazawa S; Suzukawa K; Morishita K; Toyama K
Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006
[TBL] [Abstract][Full Text] [Related]
39. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
[TBL] [Abstract][Full Text] [Related]
40. SCL assembles a multifactorial complex that determines glycophorin A expression.
Lahlil R; Lécuyer E; Herblot S; Hoang T
Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
